The pharmaceutical industry's export market share in Italy stood at 5.26% in 2023. Forecasted data indicates a slight decline to 5.25% in 2024, followed by stabilization at 5.24% from 2025 through 2028. The year-on-year variation shows a minor decrease from 2023 to 2024 by 0.19%, with no change in the subsequent years. The Compound Annual Growth Rate (CAGR) over this five-year period is predicted to remain flat at 0.00%, suggesting minimal growth in export market share.
Future trends to watch for include potential impacts from regulatory changes within the EU, advancements in pharmaceutical technology, and shifts in global demand. Additionally, Italy's ability to innovate and expand into emerging markets will be crucial for maintaining or growing its export market share.